What is PEN stock price today?

PEN (Penumbra Inc) stock is trading at $332.13 as of the latest market data. Stock prices update in real-time during market hours (9:30 AM - 4:00 PM ET).

Is PEN stock going up or down today?

PEN stock price movements are influenced by market conditions, news, earnings reports, and investor sentiment. Check our live dashboard for real-time price changes and technical indicators.

Should I buy PEN stock now?

The decision to buy PEN depends on your investment strategy, risk tolerance, and financial goals. Our AI analysis evaluates fundamentals, valuation metrics, growth prospects, and market conditions to help inform your decision.

Is PEN a buy, hold, or sell right now?

Our AI-powered analysis provides buy/hold/sell recommendations for PEN based on multiple factors including valuation, growth metrics, technical indicators, and analyst consensus. Visit our dashboard for the latest recommendation.

Is PEN stock overvalued or undervalued?

PEN currently trades at a P/E ratio of 73.48, which may indicate premium valuation. Our DCF calculator provides intrinsic value estimates to help determine if PEN is fairly priced.

What is PEN's P/E ratio?

PEN has a price-to-earnings (P/E) ratio of 73.48, which measures how much investors are willing to pay per dollar of earnings. Compare this to industry peers and historical averages for context.

What is PEN's market cap?

PEN (Penumbra Inc) has a market capitalization of $13.03 billion, making it a mid-cap stock.

What is PEN's price to book ratio?

PEN trades at a price-to-book (P/B) ratio of 9.13, which compares the stock price to the company's book value per share. A P/B below 1.0 may indicate undervaluation, while above 3.0 may suggest premium pricing.

Does PEN pay dividends?

PEN does not currently pay dividends. Many growth companies reinvest profits into the business rather than paying dividends.

What is PEN's dividend yield?

PEN does not currently pay dividends or dividend data is not available. Check our dashboard for the latest information.

Is PEN stock a good long-term investment?

PEN's long-term investment potential depends on sustainable competitive advantages, revenue growth, profitability, management quality, and industry dynamics. Our AI analysis evaluates these factors to assess long-term prospects.

What is PEN's revenue growth rate?

PEN has shown revenue growth of 0.2% over recent periods. Consistent revenue growth is a key indicator of business health and competitive positioning.

Yes, PEN is profitable with a profit margin of 0.1%. This indicates the company generates 0.1 cents of profit for every dollar of revenue.

What are the risks of investing in PEN?

Key risks for PEN include market volatility, competitive pressures, regulatory changes, economic conditions, execution risks, and company-specific factors. Our AI analysis identifies material risks and their potential impact on valuation.

How does PEN compare to its competitors?

Compare PEN to industry peers on our dashboard using metrics like P/E ratio, revenue growth, profit margins, market share, and valuation multiples. Competitive analysis helps contextualize PEN's performance and positioning.

What is PEN's stock price target for 2026?

Our AI model provides price targets for PEN based on fundamental analysis: Bull case $431.77 (+30%), Base case $381.95 (+15%), Bear case $298.92 (-10%). Visit our prediction page for detailed forecasts.

What do analysts say about PEN?

Wall Street analysts provide ratings (buy/hold/sell) and price targets for PEN. Our dashboard aggregates analyst consensus, target prices, and recent upgrades/downgrades to help you understand professional sentiment.

When is PEN's next earnings report?

PEN reports earnings quarterly. Check our dashboard for the upcoming earnings date, analyst estimates for revenue and EPS, and historical earnings performance. Earnings reports often drive significant stock price movements.

PEN - Penumbra Inc

NYSE * Health Care * Health Care Equipment & Supplies

$332.13

+$0.66 (+0.20%)

About Penumbra Inc

Penumbra, Inc., together with its subsidiaries, designs, develops, manufactures, and markets medical devices in the United States and internationally. It offers computer-assisted vacuum thrombectomy; peripheral thrombectomy products, including the Indigo System for power aspiration of thrombus in the body; Lightning Flash, a mechanical thrombectomy system; Lightning Bolt 7, an arterial thrombectomy system; and CAT RX. It also provides access products, including guide catheters and the Penumbra distal delivery catheters under the Neuron, Neuron MAX, BENCHMARK, BMX, DDC, Access25; MIDWAY, and PX SLIM brands; Penumbra System, an integrated mechanical thrombectomy system comprising reperfusion catheters and separators, the 3D Revascularization device, aspiration tubing, aspiration pump, and other components and accessories under the Penumbra RED, SENDit, JET, ACE, BMX, Max, 3D Revascularization Device, and Penumbra ENGINE brands; and neuro embolization coiling systems that include the Penumbra Coil 400, for the treatment of aneurysms and other complex lesions, detachable coils of neurovascular lesions under the Penumbra SMART COIL, SwiftSET, and Penumbra SwiftPAC Coil brands; and POD400 and PAC400 brands. In addition, it provides peripheral embolization products, such as Ruby Embolization Platform, which consists of detachable coils for peripheral applications; Ruby LP and XL Embolization Platform; Penumbra LANTERN Delivery Microcatheter, a low-profile microcatheter with a high-flow lumen; POD (Penumbra Occlusion Device) System, a single device solution; Packing Coil LP; and Packing Coil, a complementary device for use in other peripheral embolization products. Further, it offers neurosurgical tools comprising the Artemis Neuro Evacuation Device for surgical removal of fluid and tissue from the ventricles and cerebrum. It sells its products through direct sales organizations and distributors. The company was incorporated in 2004 and is based in Alameda, California.

PEN Key Statistics

Market Cap

$13.03B

P/E Ratio

73.48

P/B Ratio

9.13

EPS

$4.52

Revenue Growth

+0.2%

Profit Margin

0.1%

Employees

4,700

How PEN Compares to Peers

PEN trades at a premium valuation vs peers (highest P/E)

PEN has the highest profit margins in Health Care Equipment & Supplies

PEN has the fastest revenue growth among competitors

P/E Rank

of 2

Margin Rank

of 2

Growth Rank

of 2

Size Rank

of 2

Company	Market Cap	P/E	Growth	Margin	Compare
PEN(This stock)	$13.03B	73.5	0%	0.1%	-
AMZNAmazon Com	$2.69T	34.9	0%	0.1%	vs AMZN

Penumbra Inc Company Information

Headquarters: California; U.S.A
Website: www.penumbrainc.com
Sector: Health Care
Industry: Health Care Equipment & Supplies

PEN - Penumbra Inc

About Penumbra Inc

PEN Key Statistics

How PEN Compares to Peers

Penumbra Inc Company Information

PEN Lician Score

PEN Financial Snowflake

Upcoming Events for PEN